Godavari Drugs Limited (GODAVARI.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹119.90 (-2.04%) as of
Key statistics
- Market cap
- 1.31B
- P/E (TTM)
- 23.98
- EPS (TTM)
- 5.00
- Dividend yield
- 0.00%
- 52-week range
- 69.70 – 144.35
- Beta
- 0.45
- Revenue (TTM)
- 1.11B
- Profit margin
- 3.75%
- Volume
- 3.62k
About Godavari Drugs Limited
Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin hydrochloride (HCL), ciprofloxacin lactate, ciprofloxacin betaine, carbamazepine, enrofloxacin, mefenamic acid, ambroxol hydrochloride, piracetam, as well as 2,5-dihydroxy-1,4- dithiane. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Secunderabad, India
- Employees
- 112
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- GANGA FORGING LIMITED (GANGAFORGE.NS)
- SEL MANUFACTURING CO LTD (SELMC.NS)
- TGB BANQUETS&HOTELS LTD (TGBHOTELS.NS)
- Kalyan Capitals Limited (KALYANCAP.BO)
- UNIFINZ CAPITAL INDIA LIMITED (UCIL.BO)
- E-Land Apparel Limited (ELAND.BO)
- ICICI Prudential NV20 ETF (NV20IETF.BO)
- MANGAL CREDIT AND FINCORP LTD. (MANCREDIT.BO)